These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current approaches in the treatment of Alzheimer's disease. Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies. Cummings JL Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636 [TBL] [Abstract][Full Text] [Related]
14. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
15. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of current Alzheimer's disease treatments: a descriptive review. Cummings JL; Mackell J; Kaufer D Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950 [TBL] [Abstract][Full Text] [Related]
17. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Beier MT Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151 [TBL] [Abstract][Full Text] [Related]
18. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273 [TBL] [Abstract][Full Text] [Related]
19. [Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?]. Checler F; Buée L Ann Pharm Fr; 2009 Mar; 67(2):136-53. PubMed ID: 19298897 [TBL] [Abstract][Full Text] [Related]
20. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A; Alfaro V Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]